Literature DB >> 15140160

Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides.

N E Robinson1, Z W Robinson, B R Robinson, A L Robinson, J A Robinson, M L Robinson, A B Robinson.   

Abstract

Nonenzymatic deamidation rates for 52 glutaminyl and 52 asparaginyl pentapeptides in pH 7.4, 37.0 degrees C. 0.15 m Tris-HCl buffer have been determined by direct injection mass spectrometry. These and the previously reported 306 asparginyl rates have been combined in a self-consistent model for peptide deamidation. This model depends quantitatively upon peptide structure and involves succinimide, glutarimide and hydrolysis mechanisms. The experimental values and suitable interpolated values have been combined to provide deamidation rate values in pH 7.4, 37.0 degrees C. 0.15 m Tris-HCl buffer for the entire set of 648 single-amide permutations of ordinary amino acid residues in GlyXxxAsnYyyGly and GlyXxxGlnYyyGly. Thus, knowledge about sequence-dependent deamidation in peptides is extended to include very long deamidation half-times in the range of 2-50 years.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15140160     DOI: 10.1111/j.1399-3011.2004.00151.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  57 in total

Review 1.  N-glycoprotein macroheterogeneity: biological implications and proteomic characterization.

Authors:  Lucia F Zacchi; Benjamin L Schulz
Journal:  Glycoconj J       Date:  2015-12-05       Impact factor: 2.916

2.  Characterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77.

Authors:  David F Nellis; Dennis F Michiel; Man-Shiow Jiang; Dominic Esposito; Richard Davis; Hengguang Jiang; Angela Korrell; George C Knapp; Lauren E Lucernoni; Roy E Nelson; Emily M Pritt; Lauren V Procter; Mark Rogers; Terry L Sumpter; Vinay V Vyas; Timothy J Waybright; Xiaoyi Yang; Amy M Zheng; Jason L Yovandich; John A Gilly; George Mitra; Jianwei Zhu
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

Review 3.  The etiology of human age-related cataract. Proteins don't last forever.

Authors:  Roger J W Truscott; Michael G Friedrich
Journal:  Biochim Biophys Acta       Date:  2015-08-28

4.  Role of glutamine deamidation in neurodegenerative diseases associated with triplet repeat expansions: a hypothesis.

Authors:  Qurratulain Hasan; Ravindra Varma Alluri; Pragna Rao; Yog Raj Ahuja
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

5.  Palaeoproteomic evidence identifies archaic hominins associated with the Châtelperronian at the Grotte du Renne.

Authors:  Frido Welker; Mateja Hajdinjak; Sahra Talamo; Klervia Jaouen; Michael Dannemann; Francine David; Michèle Julien; Matthias Meyer; Janet Kelso; Ian Barnes; Selina Brace; Pepijn Kamminga; Roman Fischer; Benedikt M Kessler; John R Stewart; Svante Pääbo; Matthew J Collins; Jean-Jacques Hublin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-16       Impact factor: 11.205

6.  Hyperunstable matrix proteins in the byssus of Mytilus galloprovincialis.

Authors:  Jason Sagert; J Herbert Waite
Journal:  J Exp Biol       Date:  2009-07       Impact factor: 3.312

7.  Multivariate analysis of the sequence dependence of asparagine deamidation rates in peptides.

Authors:  Andrew A Kosky; Vasumathi Dharmavaram; Gayathri Ratnaswamy; Mark Cornell Manning
Journal:  Pharm Res       Date:  2009-09-09       Impact factor: 4.200

8.  Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain.

Authors:  Amy J Gleichman; Lynn A Spruce; Josep Dalmau; Steven H Seeholzer; David R Lynch
Journal:  J Neurosci       Date:  2012-08-08       Impact factor: 6.167

9.  Isoaspartyl protein damage and repair in mouse retina.

Authors:  Zhenxia Qin; Jing Yang; Henry J Klassen; Dana W Aswad
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-13       Impact factor: 4.799

10.  Age-dependent deamidation of lifelong proteins in the human lens.

Authors:  Peter G Hains; Roger J W Truscott
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-06       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.